BRIEF-Keros Therapeutics Presents Results From Preclinical Study Of Rker-012 In Pulmonary Arterial Hypertension At Pulmonary Hypertension Association International Conference And Scientific Sessions
* KEROS THERAPEUTICS PRESENTS RESULTS FROM A PRECLINICAL STUDY OF RKER-012 IN PULMONARY ARTERIAL HYPERTENSION AT PULMONARY HYPERTENSION ASSOCIATION INTERNATIONAL CONFERENCE AND SCIENTIFIC SESSIONS Source text for Eikon: Further company coverage: